EXOZ eXoZymes Inc.
Price (delayed)
$10.12
Market cap
$84.68M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.89
Enterprise value
$76.35M
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.
Highlights
The debt has plunged by 76% from the previous quarter and by 47% YoY
eXoZymes's revenue has soared by 100% from the previous quarter but it has plunged by 100% YoY
The gross profit has surged by 100% since the previous quarter but it has dropped by 100% year-on-year
eXoZymes's net income has plunged by 188% YoY and by 14% from the previous quarter
The EPS has plunged by 170% YoY and by 7% from the previous quarter
Key stats
What are the main financial stats of EXOZ
Market
Valuations
Earnings
Shares outstanding
8.37M
Market cap
$84.68M
Enterprise value
$76.35M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.89
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$5.93M
Net income
-$5.86M
EBIT
-$5.94M
EBITDA
-$5.64M
Free cash flow
-$8.9M
Per share
Balance sheet
Liquidity
EPS
-$0.89
EPS diluted
-$0.89
Free cash flow per share
-$1.36
Book value per share
$1.28
Revenue per share
$0
TBVPS
$1.99
Total assets
$13.03M
Total liabilities
$2.61M
Debt
$1.39M
Equity
$10.42M
Working capital
$9.49M
Debt to equity
0.13
Current ratio
8.12
Quick ratio
7.84
Net debt/EBITDA
1.48
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-95.1%
Return on equity
-708.9%
Return on invested capital
-173%
Return on capital employed
-50.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EXOZ stock price
How has the eXoZymes stock price performed over time
Intraday
-4.98%
1 week
-19.75%
1 month
-40.12%
1 year
N/A
YTD
-38.67%
QTD
-3.16%
Financial performance
How have eXoZymes's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$5.93M
Net income
-$5.86M
Gross margin
N/A
Net margin
N/A
eXoZymes's net income has plunged by 188% YoY and by 14% from the previous quarter
eXoZymes's revenue has soared by 100% from the previous quarter but it has plunged by 100% YoY
The gross profit has surged by 100% since the previous quarter but it has dropped by 100% year-on-year
eXoZymes's operating income has decreased by 20% from the previous quarter
Growth
What is eXoZymes's growth rate over time
Valuation
What is eXoZymes stock price valuation
P/E
N/A
P/B
7.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 170% YoY and by 7% from the previous quarter
eXoZymes's revenue has soared by 100% from the previous quarter but it has plunged by 100% YoY
Efficiency
How efficient is eXoZymes business performance
eXoZymes's ROIC has plunged by 151% YoY and by 21% from the previous quarter
The ROE has plunged by 72% YoY
EXOZ's ROA is down by 46% YoY but it is up by 30% from the previous quarter
Dividends
What is EXOZ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EXOZ.
Financial health
How did eXoZymes financials performed over time
EXOZ's total liabilities has shrunk by 64% QoQ and by 34% YoY
The debt is 87% less than the equity
EXOZ's debt to equity has soared by 108% QoQ and by 102% YoY
The debt has plunged by 76% from the previous quarter and by 47% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.